Form 4 for EBS Emergent BioSolutions Inc.
Accepted 2024-03-04 00:00:00 ET · period of report 2024-02-29 · accession 0001367644-24-000019 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-03-04 | 2024-02-29+ | EBS | Fox Jennifer Lynne | EVP, GC, Ext Aff, Corp Sec | F - Tax | $3.25 | -4,806 | 174.5K | -3% | -$15.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-01 | F | D | 703 | $3.39 | 173,758 | D | — | — | (F1) Represents shares of common stock withheld to pay taxes. |
| 2 | Common | Common Stock | 2024-02-29 | F | D | 4,103 | $3.23 | 174,461 | D | — | — | (F1) Represents shares of common stock withheld to pay taxes. |